Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of QVA149 vs Tiotropium in Japanese COPD Patients
NCT01285492Phase 3Completed
- Sponsor
- Novartis
- Start
- Jan 2011
- Primary completion
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indacaterol + glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Jan 2011; status: completed.
02
Drugs
indacaterol + glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01285492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285492.